# YESCARTA

NDC: 71287-119
Generic name: axicabtagene ciloleucel
Labeler / Manufacturer: Kite Pharma, Inc.
Product type: CELLULAR THERAPY
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20171018

FDA application: BLA125643

## Active ingredients

- AXICABTAGENE CILOLEUCEL: 2000000 1/68mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71287-119"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71287-119
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9b70606e-b99c-4272-a0f1-b5523cce0c59